▁There 5.83203125
▁is 1.626953125
▁currently 4.72265625
▁a 1.4619140625
▁severe 5.44140625
▁lack 2.92578125
▁of 0.0206146240234375
▁information 3.65625
▁about 1.4462890625
▁the 0.7919921875
▁effects 3.875
▁of 0.1082763671875
▁op 6.61328125
i 3.775390625
ates 0.028350830078125
. 3.91015625
▁They 5.02734375
▁manage 9.1875
▁pain 2.126953125
▁successfully 6.66796875
, 1.00390625
▁but 0.283447265625
▁the 2.6328125
▁past 8.8984375
▁few 1.150390625
▁dec 1.5859375
ades 3.6597251892089844e-05
▁indicated 9.8828125
▁the 2.80859375
▁growing 3.595703125
▁concern 3.19140625
▁regarding 3.37109375
▁op 1.9833984375
iate 0.40185546875
▁ab 1.3798828125
use 0.0094146728515625
▁in 3.419921875
▁forms 9.8515625
▁of 0.2381591796875
▁over 3.35546875
d 0.0738525390625
ose 0.31982421875
▁and 0.79541015625
▁add 0.52490234375
iction 0.01433563232421875
. 0.09808349609375
▁A 4.12890625
▁more 5.3828125
▁manage 9.1015625
able 0.00284576416015625
▁and 2.099609375
▁sa 2.26171875
fer 0.0001596212387084961
▁alternative 1.9326171875
▁might 4.98046875
▁be 0.2481689453125
▁medical 5.8203125
▁mar 0.386474609375
iju 0.0010805130004882812
ana 4.756450653076172e-05
. 0.61962890625
▁However 4.3359375
, 0.0156707763671875
▁the 1.8798828125
▁legal 3.5546875
▁status 1.0693359375
▁and 3.41015625
▁novel 10.4609375
ty 0.212646484375
▁of 0.1463623046875
▁this 1.8681640625
▁drug 1.962890625
▁do 4.91796875
▁not 0.0391845703125
▁allow 0.98291015625
▁finding 7.9765625
▁a 2.63671875
▁large 3.37890625
▁number 0.97216796875
▁of 0.004169464111328125
▁studies 0.923828125
▁on 1.787109375
▁its 1.1279296875
▁effect 2.193359375
iveness 0.181640625
. 0.6806640625
▁Specifically 8.984375
, 0.08868408203125
▁it 2.787109375
▁concerns 5.34375
▁the 0.99365234375
▁emot 9.828125
ional 0.0372314453125
▁condition 5.36328125
▁of 0.623046875
▁patients 1.1826171875
▁experien 6.1328125
cing 9.5367431640625e-05
▁chron 1.0595703125
ic 0.0005893707275390625
▁pain 0.08697509765625
. 0.386474609375
▁This 3.044921875
▁research 2.75390625
▁paper 2.28125
▁a 1.650390625
ims 0.0002751350402832031
▁to 0.128662109375
▁analyze 2.8046875
▁levels 10.6796875
▁of 0.037017822265625
▁de 1.8427734375
pression 0.055816650390625
▁and 0.67919921875
▁anx 0.1328125
iety 0.0002694129943847656
▁among 1.494140625
▁people 2.515625
▁receiving 4.2109375
▁ther 4.98046875
apy 0.0355224609375
▁by 4.61328125
▁comparing 10.3046875
▁the 1.875
▁effects 2.451171875
▁of 0.0289154052734375
▁ph 5.6328125
arma 0.354736328125
ce 0.01131439208984375
ut 0.0002663135528564453
ical 0.0173492431640625
▁op 1.4140625
io 2.65625
ids 0.09234619140625
▁and 0.501953125
▁MM 4.1953125
. 2.421875
<0x0A> 0.3994140625
Chr 4.12109375
onic 0.00745391845703125
▁pain 0.141845703125
▁is 0.876953125
▁still 6.37890625
▁considered 3.005859375
▁to 1.7548828125
▁be 0.039764404296875
▁an 2.83984375
▁extreme 6.6328125
▁issue 3.474609375
▁among 3.251953125
▁at 9.375
▁least 0.09423828125
▁ 0.348388671875
8 3.80078125
% 1.837890625
▁of 0.050384521484375
▁the 0.7275390625
▁residents 7.52734375
▁of 0.364013671875
▁progress 12.078125
ive 0.12213134765625
▁countries 0.44775390625
. 0.453369140625
▁The 2.078125
▁introduction 6.95703125
▁of 0.014404296875
▁the 3.111328125
▁study 6.71875
▁describes 5.32421875
▁the 0.55810546875
▁apparent 9.1796875
▁link 3.7109375
▁between 0.08013916015625
▁pain 2.134765625
▁and 0.358642578125
▁dem 9.15625
oral 1.4599609375
ization 0.06976318359375
. 0.8271484375
▁Chron 4.58984375
ic 0.00878143310546875
▁pain 0.192138671875
▁is 1.5009765625
▁always 5.421875
▁accompanied 1.544921875
▁by 0.053802490234375
▁negative 3.892578125
▁emot 0.501953125
ional 1.169921875
▁experiences 3.173828125
▁and 2.50390625
▁blocks 11.4375
▁a 2.87890625
▁person 0.75537109375
’ 0.66259765625
s 0.0014362335205078125
▁ability 1.1796875
▁to 0.02301025390625
▁receive 6.49609375
▁joy 3.3515625
▁and 1.6748046875
▁satisfaction 2.353515625
▁from 0.701171875
▁life 0.822265625
. 0.225830078125
▁The 1.9384765625
▁research 2.76171875
▁investig 5.89453125
ates 0.30859375
▁the 0.5146484375
▁development 6.890625
▁of 0.053253173828125
▁de 1.0048828125
pression 0.1514892578125
▁and 0.264892578125
▁anx 0.048919677734375
iety 0.0004925727844238281
▁among 1.142578125
▁patients 0.9794921875
▁receiving 2.26171875
▁ph 3.09765625
arma 0.096923828125
ce 0.003082275390625
ut 1.6570091247558594e-05
ical 0.006038665771484375
▁op 0.69580078125
io 0.262939453125
ids 0.12548828125
▁and 0.7666015625
▁medical 1.177734375
▁mar 0.1038818359375
iju 0.0004916191101074219
ana 2.86102294921875e-05
▁( 2.810546875
MM 0.456298828125
) 1.2490234375
▁as 1.7734375
▁severe 10.3203125
▁pain 0.498046875
kill 2.56640625
ers 0.0002315044403076172
. 0.138427734375
▁It 2.98046875
▁comp 4.20703125
ares 0.006404876708984375
▁the 0.484130859375
▁effic 4.37109375
acy 0.00310516357421875
▁of 0.2132568359375
▁pres 6.453125
cri 2.5
ptions 0.82177734375
▁and 1.3818359375
▁exam 4.65625
ines 0.00708770751953125
▁the 0.59619140625
▁possibility 3.775390625
▁of 0.1256103515625
▁post 9.5
- 0.962890625
tre 1.578125
at 0.00186920166015625
ment 0.0032367706298828125
▁de 1.4560546875
pression 0.053802490234375
. 1.4248046875
<0x0A> 0.462890625
The 0.68798828125
▁study 1.7861328125
▁was 2.466796875
▁conducted 0.59716796875
▁in 1.220703125
▁the 1.416015625
▁form 2.5390625
▁of 0.001583099365234375
▁collection 11.625
▁and 0.68310546875
▁analysis 0.35888671875
▁of 0.010223388671875
▁statistical 3.703125
▁data 0.11444091796875
. 0.79931640625
▁Part 5.109375
icip 0.1767578125
ants 0.058013916015625
▁were 0.67529296875
▁rec 3.85546875
ru 0.0011281967163085938
ited 0.00019156932830810547
▁for 4.12109375
▁six 6.50390625
▁months 0.54248046875
▁at 4.21484375
▁two 2.7265625
▁major 4.015625
▁pain 2.69921875
▁relief 4.203125
▁cent 0.76513671875
ers 0.0281219482421875
▁in 0.7138671875
▁Israel 5.50390625
. 0.300537109375
▁The 1.2421875
▁research 2.27734375
ers 1.3408203125
▁used 2.263671875
▁The 7.359375
▁De 3.177734375
pression 0.024017333984375
▁Module 6.55078125
▁of 0.73828125
▁the 0.2132568359375
▁Pat 3.173828125
ient 0.0104217529296875
▁Health 0.039764404296875
▁Question 0.019622802734375
naire 0.0278472900390625
▁and 2.638671875
▁the 0.82373046875
▁General 1.201171875
ized 0.6875
▁An 0.005069732666015625
x 0.0001163482666015625
iety 0.0003962516784667969
▁Dis 0.133056640625
order 0.0215301513671875
▁Sc 1.4619140625
ale 0.002719879150390625
▁to 0.86376953125
▁interview 7.546875
▁participants 2.646484375
, 4.4921875
▁evaluate 4.46484375
▁their 0.58056640625
▁answers 4.14453125
, 0.257080078125
▁and 0.029510498046875
▁conduct 4.90234375
▁the 1.8916015625
▁study 2.306640625
. 0.10284423828125
▁To 4.96875
▁specifically 10.078125
▁evaluate 3.451171875
▁and 5.1953125
▁compare 0.517578125
▁the 0.423095703125
▁prob 9.8671875
abilities 0.039947509765625
▁of 0.0689697265625
▁de 0.91845703125
pression 0.03302001953125
▁or 4.45703125
▁anx 0.047149658203125
iety 0.0005350112915039062
▁among 1.568359375
▁the 2.1328125
▁diverse 9.40625
▁groups 0.80078125
, 0.68505859375
▁the 0.410400390625
▁study 2.68359375
▁used 1.3203125
▁multiple 5.26953125
▁log 0.6103515625
istic 0.02685546875
▁regression 0.297607421875
▁analysis 1.392578125
▁and 2.75
▁chose 8.5625
▁medical 6.25390625
▁mar 0.09423828125
iju 0.0010004043579101562
ana 3.981590270996094e-05
▁as 0.5537109375
▁the 0.873046875
▁control 2.8359375
▁group 0.61865234375
. 0.263916015625
<0x0A> 0.349365234375
This 4.0859375
▁type 5.79296875
▁of 0.00206756591796875
▁study 1.3955078125
▁is 1.287109375
▁the 3.623046875
▁most 1.26171875
▁reve 7.9765625
aling 0.0005035400390625
▁and 1.4619140625
▁inclus 7.03515625
ive 0.0007433891296386719
, 3.115234375
▁as 1.2548828125
▁it 0.341796875
▁contains 4.62890625
▁direct 5.984375
▁responses 5.51953125
▁from 0.5791015625
▁a 3.59375
▁large 0.90869140625
▁number 0.448974609375
▁of 0.0022716522216796875
▁participants 0.93701171875
. 0.53466796875
▁All 5.328125
▁tools 7.81640625
▁in 5.7578125
▁the 0.80419921875
▁form 3.9296875
▁of 0.019317626953125
▁question 0.7158203125
na 0.013702392578125
ires 0.00035309791564941406
▁and 1.2041015625
▁scales 2.6640625
▁have 3.435546875
▁already 3.935546875
▁been 0.41162109375
▁used 2.18359375
▁and 1.849609375
▁proved 2.369140625
▁their 1.4462890625
▁effic 2.5390625
acy 0.00276947021484375
▁for 3.578125
▁collect 4.01171875
ing 0.003559112548828125
▁analyt 7.25
ical 0.09228515625
▁data 0.1673583984375
. 0.335693359375
▁It 3.22265625
▁helps 4.23828125
▁to 0.6953125
▁system 6.96875
at 0.53955078125
ize 0.001697540283203125
▁and 1.2958984375
▁class 4.87890625
ify 0.0018663406372070312
▁distinct 8.1796875
▁kinds 6.37109375
▁of 0.0151214599609375
▁information 2.30078125
▁for 4.015625
▁subsequent 5.11328125
▁un 8.78125
comp 4.4296875
licated 0.024932861328125
▁services 12.59375
. 0.54443359375
▁Thus 4.76171875
, 0.003971099853515625
▁research 4.28515625
ers 0.2275390625
▁can 1.6474609375
▁compare 2.5
▁the 1.0224609375
▁effects 2.755859375
▁of 0.09307861328125
▁medic 3.75390625
ations 0.62451171875
▁on 1.6669921875
▁patients 2.005859375
▁of 4.2265625
▁diverse 2.984375
▁age 1.958984375
▁groups 2.28125
, 0.74169921875
▁background 3.703125
s 0.1141357421875
, 0.01214599609375
▁physical 5.69140625
▁conditions 1.3583984375
, 0.028594970703125
▁emot 6.38671875
ional 0.0305023193359375
▁states 1.345703125
, 0.03643798828125
▁and 0.3779296875
▁so 2.56640625
▁on 0.203125
. 0.0626220703125
<0x0A> 0.78271484375
The 0.7333984375
▁analysis 3.921875
▁of 0.67578125
▁any 9.4921875
▁human 6.98828125
▁reaction 4.03125
▁has 4.84375
▁a 1.8232421875
▁high 3.052734375
▁potential 3.173828125
▁of 2.0859375
▁subject 2.9140625
iveness 3.529296875
▁and 1.2978515625
▁bias 1.7724609375
, 2.0703125
▁especially 2.158203125
▁regarding 3.623046875
▁people 5.1171875
▁in 3.771484375
▁severe 2.65625
▁pain 0.6318359375
▁and 2.330078125
▁un 5.67578125
stable 0.8955078125
▁emot 0.64306640625
ional 0.080322265625
▁condition 2.521484375
. 0.0438232421875
▁Perhaps 8.28125
▁some 5.25390625
▁patients 1.9345703125
▁tend 4.70703125
▁to 0.0088958740234375
▁ex 2.046875
agger 0.00872039794921875
ate 0.0013322830200195312
▁their 0.96435546875
▁de 3.0234375
press 1.8134765625
ive 0.06451416015625
▁state 2.423828125
▁or 1.63671875
▁vice 5.91015625
▁vers 0.0238800048828125
a 3.7550926208496094e-05
, 1.056640625
▁de 7.44140625
- 2.517578125
emph 0.429931640625
as 0.0022335052490234375
ize 0.06182861328125
▁serious 6.76171875
▁difficulties 5.7109375
. 0.80908203125
▁Because 6.25
▁the 2.779296875
▁survey 5.13671875
▁responses 7.04296875
▁were 1.5751953125
▁thoroughly 8.5625
▁anonymous 3.13671875
, 0.2445068359375
▁the 1.2138671875
▁research 1.044921875
ers 0.1986083984375
▁were 2.611328125
▁unable 2.87109375
▁to 0.0011587142944335938
▁carefully 7.890625
▁analyze 2.60546875
▁each 2.431640625
▁patient 2.447265625
’ 0.58447265625
s 0.0005002021789550781
▁reaction 3.845703125
▁and 1.3349609375
▁compare 3.595703125
▁it 0.84912109375
▁to 0.64404296875
▁the 0.95849609375
▁actual 4.4375
▁states 7.6015625
▁of 0.75341796875
▁condition 6.7578125
. 0.300048828125
▁More 6.51171875
▁accurate 3.177734375
▁answers 4.40234375
▁could 1.8603515625
▁be 0.75244140625
▁obtained 1.0205078125
▁by 1.373046875
▁professional 5.953125
▁psych 1.1708984375
olog 0.38037109375
ists 0.00118255615234375
▁via 7.28515625
▁personal 2.60546875
▁communication 4.25
▁and 2.025390625
▁behavior 6.25
al 0.26123046875
▁analysis 1.9736328125
. 0.2384033203125
▁However 2.89453125
, 0.0002644062042236328
▁this 1.39453125
▁method 2.240234375
▁of 2.7109375
▁research 1.8095703125
▁is 1.1298828125
▁way 5.64453125
▁more 0.82861328125
▁resource 4.83203125
- 0.253173828125
int 1.44140625
ensive 0.0242462158203125
▁and 0.411376953125
▁energy 10.765625
- 0.0670166015625
consum 0.359130859375
ing 0.0017547607421875
. 0.67138671875
<0x0A> 0.37451171875
Part 5.94140625
icip 0.1727294921875
ants 0.13427734375
▁were 1.318359375
▁rec 1.90625
ru 0.0004878044128417969
ited 4.887580871582031e-06
▁for 1.90625
▁six 0.38720703125
▁months 0.007083892822265625
▁at 0.401123046875
▁two 0.07977294921875
▁major 0.1011962890625
▁pain 0.03741455078125
▁relief 0.023651123046875
▁cent 0.01242828369140625
ers 0.0007529258728027344
▁in 0.04241943359375
▁Israel 0.00925445556640625
. 0.1873779296875
▁All 4.3984375
▁patients 1.6826171875
▁experienced 4.21875
▁chron 0.78662109375
ic 0.000156402587890625
▁pain 0.182861328125
▁for 2.296875
▁at 0.62646484375
▁least 0.0014295578002929688
▁ 1.8798828125
3 1.5078125
▁months 0.2049560546875
. 1.23046875
▁The 1.4052734375
▁study 1.5703125
▁included 1.7060546875
▁ 0.55224609375
8 3.015625
9 2.4609375
0 2.90625
▁participants 1.5390625
, 1.3623046875
▁of 2.8046875
▁which 0.41357421875
▁ 0.09521484375
4 1.3486328125
7 2.603515625
4 2.615234375
▁( 3.181640625
5 0.09716796875
9 4.87109375
%) 0.6943359375
▁were 0.83984375
▁treated 3.103515625
▁sole 6.99609375
ly 0.00014340877532958984
▁with 0.32080078125
▁op 1.3759765625
io 0.31787109375
ids 0.156005859375
, 0.54248046875
▁ 0.728515625
3 1.2822265625
2 2.24609375
9 2.46875
▁( 0.04638671875
4 2.52734375
1 1.3193359375
%) 0.057037353515625
▁were 1.5341796875
▁treated 0.662109375
▁with 0.397705078125
▁MM 0.76171875
, 0.3134765625
▁and 0.1080322265625
▁ 0.2213134765625
7 2.009765625
7 2.392578125
▁( 0.1185302734375
8 1.931640625
. 0.86865234375
6 2.42578125
%) 0.0662841796875
▁acquired 10.2734375
▁both 0.6201171875
▁( 5.0546875
Fe 9.25
ing 1.3427734375
old 0.395263671875
▁et 0.9560546875
▁al 0.0186614990234375
., 0.179443359375
▁ 0.014739990234375
2 0.0063934326171875
0 0.00039887428283691406
1 0.1981201171875
7 1.6142578125
). 0.05181884765625
▁The 1.1943359375
▁remaining 7.41015625
▁ten 6.6953125
▁participants 1.248046875
▁who 4.92578125
▁did 2.326171875
▁not 0.006084442138671875
▁receive 2.013671875
▁ph 4.33203125
arma 0.0869140625
ce 0.0008597373962402344
ut 1.6689300537109375e-06
ical 0.00254058837890625
▁op 2.095703125
io 0.07220458984375
ids 0.026123046875
▁and 2.609375
▁medical 1.87109375
▁mar 0.035797119140625
iju 0.00030875205993652344
ana 3.814697265625e-05
▁were 0.480712890625
▁with 6.73828125
dra 0.051605224609375
wn 4.124641418457031e-05
▁from 0.237548828125
▁the 0.1885986328125
▁analysis 2.31640625
▁in 5.17578125
▁the 1.044921875
▁research 4.2578125
. 1.0126953125
▁Therefore 5.0859375
, 0.00732421875
▁it 3.75390625
▁is 1.34765625
▁not 2.943359375
▁possible 0.6982421875
▁to 0.0046539306640625
▁compreh 5.859375
ens 0.1514892578125
ively 0.01776123046875
▁compare 1.2451171875
▁patients 5.0859375
▁taking 3.998046875
▁medic 4.140625
ations 0.483154296875
▁with 1.435546875
▁those 1.0390625
▁who 0.76318359375
▁do 1.7080078125
▁not 0.00428009033203125
. 0.5849609375
<0x0A> 0.56494140625
The 0.83349609375
▁study 1.6083984375
▁conducted 4.265625
▁a 1.7431640625
▁correlation 6.68359375
▁type 9.4296875
▁of 0.2027587890625
▁research 0.9482421875
▁with 3.5
▁variable 8.65625
▁measures 5.19140625
. 0.884765625
▁It 1.4482421875
▁evaluated 4.56640625
▁the 0.60888671875
▁inter 6.26171875
dep 2.361328125
end 0.0002722740173339844
ence 0.00769805908203125
▁of 0.6142578125
▁various 3.5234375
▁factors 0.8603515625
▁that 3.005859375
▁affected 3.986328125
▁the 0.4853515625
▁physical 6.4921875
▁and 0.281005859375
▁emot 0.454833984375
ional 0.00010597705841064453
▁condition 1.4111328125
▁of 0.043792724609375
▁patients 0.77587890625
▁experien 3.005859375
cing 7.62939453125e-06
▁chron 0.285888671875
ic 0.00014066696166992188
▁pain 0.0119781494140625
. 0.1246337890625
▁For 4.10546875
▁example 1.0341796875
, 0.0011606216430664062
▁the 1.03125
▁survey 5.7265625
▁showed 4.1015625
▁that 0.480712890625
▁the 1.8486328125
▁ratio 6.76953125
▁of 0.09271240234375
▁female 3.607421875
▁patients 1.0126953125
▁was 1.1318359375
▁remark 7.93359375
ably 0.00016617774963378906
▁higher 0.1773681640625
▁in 2.369140625
▁the 0.46142578125
▁op 3.642578125
i 2.87109375
ates 0.0129241943359375
▁group 0.222900390625
▁compared 2.513671875
▁to 0.03955078125
▁the 0.63525390625
▁MM 0.2044677734375
▁group 0.423095703125
. 0.51611328125
▁In 3.4765625
▁turn 3.806640625
, 0.0008654594421386719
▁people 4.75
▁on 4.9921875
▁op 2.982421875
i 0.64404296875
ates 0.004924774169921875
▁were 0.86083984375
▁more 1.4267578125
▁likely 0.2822265625
▁to 0.023468017578125
▁report 2.955078125
▁major 6.12890625
▁de 0.52294921875
press 0.7431640625
ive 0.0025177001953125
▁dis 0.96826171875
orders 1.6259765625
. 1.6669921875
<0x0A> 2.236328125
The 0.90087890625
▁question 5.57421875
na 0.82763671875
ires 4.4345855712890625e-05
▁used 1.8759765625
▁different 7.66796875
▁variable 8.6015625
▁measures 0.366943359375
▁to 1.7822265625
▁collect 2.484375
▁information 1.6220703125
. 1.330078125
▁For 1.638671875
▁example 0.2724609375
, 0.00116729736328125
▁it 4.11328125
▁included 2.0234375
▁compreh 8.390625
ensive 0.04925537109375
▁so 5.6875
cio 0.0011854171752929688
- 0.2734375
dem 0.1265869140625
ographic 0.0718994140625
▁data 0.8984375
: 4.87109375
▁gender 2.08984375
, 0.043792724609375
▁age 0.27490234375
, 0.036529541015625
▁country 4.22265625
, 2.529296875
▁type 4.42578125
▁of 0.053863525390625
▁residence 3.7890625
▁( 2.646484375
urban 0.75830078125
/ 1.3818359375
r 0.1451416015625
ural 0.0007023811340332031
), 0.17236328125
▁years 6.24609375
▁of 0.169189453125
▁education 0.7001953125
, 0.09014892578125
▁and 1.341796875
▁employ 2.603515625
ment 0.001697540283203125
▁status 0.64990234375
. 0.15283203125
▁Pat 4.6484375
ients 0.07611083984375
▁were 1.130859375
▁also 0.7880859375
▁asked 0.556640625
▁about 1.0263671875
▁their 0.6943359375
▁medical 2.5703125
▁history 0.54052734375
▁over 8.7421875
▁the 0.059814453125
▁years 4.61328125
▁and 1.6953125
▁the 1.47265625
▁current 3.0859375
▁presence 4.953125
▁of 0.0697021484375
▁any 2.28125
▁severe 3.6640625
▁dise 1.8837890625
ases 7.128715515136719e-05
▁such 4.53125
▁as 0.0010242462158203125
▁heart 2.58984375
▁failure 1.67578125
, 0.31494140625
▁di 1.55078125
ab 0.0007424354553222656
etes 0.002155303955078125
, 0.061981201171875
▁ar 4.09765625
th 0.1470947265625
rit 0.0242767333984375
is 0.003978729248046875
, 0.02386474609375
▁and 1.1669921875
▁so 0.76708984375
▁on 0.049346923828125
. 0.044158935546875
▁The 1.728515625
▁third 6.84375
▁measure 3.556640625
▁of 2.419921875
▁the 0.60498046875
▁question 1.6640625
naire 0.276611328125
▁was 1.11328125
▁indicated 10.7265625
▁by 1.1943359375
▁information 6.69921875
▁on 2.259765625
▁any 5.68359375
▁twelve 14.21875
- 0.1903076171875
month 0.12841796875
▁and 5.046875
▁lifetime 0.65966796875
▁drug 3.40625
▁and 1.80859375
▁alco 0.12841796875
hol 6.783008575439453e-05
▁consumption 4.39453125
. 0.39892578125
▁In 3.623046875
▁addition 0.935546875
, 0.18798828125
▁the 0.97607421875
▁record 10.3203125
▁included 1.2587890625
▁a 2.7578125
▁pain 4.6015625
▁measurement 5.1171875
▁scale 0.80078125
▁from 4.26171875
▁ 0.4775390625
0 0.278564453125
▁to 0.2255859375
▁ 0.00553131103515625
1 0.07373046875
0 0.038330078125
▁to 3.21875
▁evaluate 1.537109375
▁dis 5.953125
com 0.1199951171875
fort 0.00128936767578125
▁feelings 8.265625
▁during 4.03125
▁the 0.2783203125
▁last 1.0751953125
▁month 1.720703125
. 0.2080078125
<0x0A> 0.38720703125
Am 6.03125
ong 0.005641937255859375
▁all 2.21875
▁participants 2.138671875
▁in 3.685546875
▁the 0.158447265625
▁study 0.483642578125
, 0.036041259765625
▁ 0.84521484375
4 1.8349609375
2 2.490234375
. 1.08203125
2 2.23046875
% 0.05804443359375
▁suffered 3.763671875
▁from 0.050018310546875
▁de 1.5498046875
pression 0.264404296875
, 0.9775390625
▁and 1.2060546875
▁ 0.1346435546875
3 1.4765625
7 2.373046875
% 2.56640625
▁experienced 2.0078125
▁excess 6.91015625
ive 0.0281219482421875
▁anx 0.2037353515625
iety 0.001979827880859375
. 0.36083984375
▁The 1.431640625
▁pl 10.9609375
ur 0.71337890625
ality 0.0007529258728027344
▁of 0.10443115234375
▁de 2.419921875
press 1.265625
ive 0.0355224609375
▁dis 2.556640625
orders 0.06829833984375
▁among 3.083984375
▁patients 1.0546875
▁in 2.787109375
▁the 0.30224609375
▁op 0.537109375
i 0.37109375
ates 0.001338958740234375
, 9.09375
▁medical 3.318359375
▁mar 0.022796630859375
iju 0.0006608963012695312
ana 1.811981201171875e-05
, 0.1602783203125
▁and 0.096923828125
▁mixed 1.5322265625
▁OP 11.6875
MM 4.61328125
▁groups 0.50146484375
▁number 9.265625
ed 0.0160064697265625
▁ 0.1646728515625
5 1.6630859375
7 2.646484375
. 0.50537109375
1 2.515625
%, 0.18310546875
▁ 0.0025196075439453125
2 2.3046875
2 2.662109375
. 0.10400390625
3 2.263671875
%, 0.046630859375
▁and 0.052215576171875
▁ 0.0015630722045898438
5 1.94921875
1 2.099609375
. 0.1566162109375
4 1.8720703125
%, 0.1536865234375
▁respectively 0.0234832763671875
. 0.226806640625
▁The 1.2685546875
▁pl 3.91796875
ur 0.0098876953125
ality 1.7762184143066406e-05
▁of 0.02264404296875
▁anx 0.449462890625
iety 0.0204620361328125
▁contained 10.5390625
▁ 0.2042236328125
4 1.1181640625
8 2.369140625
. 0.173583984375
4 2.189453125
% 2.0625
▁among 2.572265625
▁OP 4.9296875
▁patients 6.33984375
, 0.276123046875
▁ 0.07489013671875
2 0.9462890625
1 2.47265625
. 0.1129150390625
5 2.11328125
% 0.0242919921875
▁among 0.460205078125
▁MM 0.093994140625
▁patients 0.39697265625
, 0.015625
▁and 0.0134735107421875
▁ 0.0241241455078125
3 1.302734375
8 1.92578125
. 0.1256103515625
7 2.2109375
% 0.01038360595703125
▁among 0.1943359375
▁OP 2.25390625
MM 0.1514892578125
▁participants 3.119140625
. 0.208740234375
▁Pat 5.0546875
ients 0.01708984375
▁who 1.9296875
▁took 2.341796875
▁strong 9.9453125
▁op 0.7021484375
i 0.7958984375
ates 0.0025920867919921875
▁were 1.1484375
▁t 10.28125
ended 1.048828125
▁to 0.006542205810546875
▁place 9.8515625
▁their 2.048828125
▁pain 1.1328125
▁on 1.9482421875
▁a 0.62744140625
▁scale 1.8291015625
▁of 0.38134765625
▁ 0.10198974609375
9 2.5625
▁to 2.36328125
▁ 0.01094818115234375
1 0.00594329833984375
0 0.006565093994140625
▁( 2.796875
Fe 1.8701171875
ing 0.0023345947265625
old 0.00040221214294433594
▁et 0.01094818115234375
▁al 0.001392364501953125
., 0.0104217529296875
▁ 0.0010728836059570312
2 0.00016379356384277344
0 2.9087066650390625e-05
1 0.0009398460388183594
7 0.00537872314453125
). 0.0101165771484375
▁They 4.56640625
▁were 1.650390625
▁also 0.85888671875
▁an 9.640625
gu 4.96484375
ished 0.08160400390625
▁em 6.328125
otion 0.0008587837219238281
ally 0.0006899833679199219
▁and 1.09375
▁react 7.52734375
ed 0.0215606689453125
▁rad 9.0546875
ically 0.0009307861328125
▁neg 4.9375
atively 0.0012035369873046875
▁to 0.1768798828125
▁almost 5.6484375
▁all 1.515625
▁survey 3.78125
▁questions 0.2276611328125
. 0.320068359375
▁Pat 3.87109375
ients 0.004241943359375
▁who 1.2568359375
▁took 1.76171875
▁only 4.296875
▁MM 0.392822265625
▁or 2.712890625
▁mixed 2.380859375
▁medic 1.2900390625
ations 0.208984375
▁course 13.890625
▁had 2.556640625
▁a 1.435546875
▁significantly 2.869140625
▁more 3.09375
▁stable 2.513671875
▁emot 0.783203125
ional 0.0008654594421386719
▁state 0.5732421875
▁and 1.12890625
▁cop 6.73046875
ed 0.0226593017578125
▁with 0.328125
▁pain 0.85205078125
▁more 1.87109375
▁manage 6.6796875
able 1.314453125
. 0.261962890625
<0x0A> 0.2132568359375
One 5.0546875
▁of 0.211669921875
▁the 0.0031986236572265625
▁major 2.767578125
▁limitations 2.4765625
▁is 2.880859375
▁the 0.469970703125
▁ins 4.703125
u 0.0718994140625
fficient 0.0865478515625
ly 3.484375
▁high 3.1015625
▁response 3.42578125
▁rate 0.0999755859375
, 2.7265625
▁ 4.5
5 1.62109375
7 2.826171875
% 2.296875
▁instead 6.30078125
▁of 0.0027370452880859375
▁ 0.45361328125
7 1.953125
0 0.448486328125
% 1.38671875
▁( 2.408203125
Fe 0.65478515625
ing 0.0018415451049804688
old 0.00029587745666503906
▁et 0.00927734375
▁al 0.0001442432403564453
., 0.0070343017578125
▁ 0.001068115234375
2 9.500980377197266e-05
0 6.282329559326172e-05
1 0.00040841102600097656
7 0.0032100677490234375
). 0.01074981689453125
▁It 1.724609375
▁can 3.09765625
▁be 0.76123046875
▁fairly 8.3125
▁explained 1.5576171875
▁by 0.200927734375
▁the 0.2822265625
▁weak 7.484375
▁focus 7.00390625
▁of 0.6875
▁respond 5.75
ents 0.116943359375
▁who 3.435546875
▁have 3.935546875
▁overcome 8.1796875
▁severe 2.02734375
▁pain 0.52490234375
▁sens 7.78125
ations 0.2022705078125
▁and 0.91845703125
▁de 4.65625
press 0.7568359375
ive 0.049041748046875
▁episodes 2.138671875
. 0.480224609375
▁It 2.78125
▁is 0.73388671875
▁not 2.546875
▁clear 3.638671875
▁how 1.9404296875
▁to 3.5703125
▁use 5.41796875
▁these 2.814453125
▁statistics 3.841796875
, 3.03515625
▁as 0.6318359375
▁they 1.951171875
▁still 5.12890625
▁may 4.88671875
▁be 1.2900390625
▁relevant 6.0546875
▁for 1.6435546875
▁the 1.880859375
▁overall 4.71484375
▁analysis 2.830078125
. 0.90576171875
